A key marker in this pathway is C-reactive protein (CRP), a liver-produced inflammatory biomarker triggered by interleukin-6 (IL-6) and other cytokines, and linked to elevated risk of CVD, metabolic syndrome, and related conditions [1, 2]. Here, CRP is linked to metabolic syndrome.